What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Omar Abdel-Wahab mainly investigates Cancer research, Mutation, Leukemia, Myeloid and Immunology.
His Cancer research research is multidisciplinary, incorporating perspectives in Enasidenib, Haematopoiesis, Cell growth, Proto-Oncogene Proteins B-raf and Molecular biology.
His Mutation study combines topics in areas such as RNA splicing, Loss function, Mutant and Function.
As part of the same scientific family, he usually focuses on Leukemia, concentrating on Myeloid leukemia and intersecting with Histone.
His research integrates issues of IDH2 and IDH1 in his study of Myeloid.
His Immunology research incorporates themes from Internal medicine and Erythropoiesis.
His most cited work include:
- Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. (1818 citations)
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate (1401 citations)
- Prognostic relevance of integrated genetic profiling in acute myeloid leukemia (1316 citations)
What are the main themes of his work throughout his whole career to date?
Cancer research, Internal medicine, Leukemia, Myeloid and Myeloid leukemia are his primary areas of study.
His research in Cancer research intersects with topics in Haematopoiesis, Mutation, Mutant and Immunology, Bone marrow.
His Haematopoiesis study deals with Molecular biology intersecting with DNA methylation.
His biological study spans a wide range of topics, including Epigenetics and RNA splicing.
His Leukemia research incorporates elements of Myelodysplastic syndromes and RUNX1.
His Myeloid study incorporates themes from Pathology and Somatic cell.
He most often published in these fields:
- Cancer research (39.33%)
- Internal medicine (21.11%)
- Leukemia (19.78%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (39.33%)
- RNA splicing (14.22%)
- Cell biology (10.00%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cancer research, RNA splicing, Cell biology, Internal medicine and Cancer.
Omar Abdel-Wahab is involved in the study of Cancer research that focuses on Myeloid in particular.
His RNA splicing research includes elements of Carcinogenesis and Mutant.
His Cell biology study also includes fields such as
- Proteome together with Mediator,
- Transcription factor that intertwine with fields like Progenitor cell.
His Internal medicine research includes themes of Gastroenterology and Oncology.
The Haematopoiesis study combines topics in areas such as DNA damage and Somatic cell.
Between 2018 and 2021, his most popular works were:
- Aberrant RNA Splicing in Cancer (185 citations)
- Aberrant RNA Splicing in Cancer (185 citations)
- Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia (79 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His primary areas of investigation include RNA splicing, Cell biology, Cancer research, Gene and Cancer.
Omar Abdel-Wahab focuses mostly in the field of RNA splicing, narrowing it down to topics relating to Exon and, in certain cases, Myeloid leukemia, Psychological repression and Mutagenesis.
The study incorporates disciplines such as Chromosomal translocation, Hematology, KRAS, Histiocytosis and Leukemia in addition to Cancer research.
Leukemia is a subfield of Internal medicine that he explores.
Omar Abdel-Wahab has included themes like Haematopoiesis and Stem cell in his Transcriptome study.
His Haematopoiesis study also includes
- Progenitor cell which intersects with area such as DNA methylation,
- Genotype that connect with fields like Somatic cell and Myeloid.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
